A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
スポンサーリンク
概要
- 論文の詳細を見る
Antiangiogenesis has been the focus of a new strategy for the treatment of obesity. However, little is known regarding the issue of whether targeting angiogenesis by nanoparticle-targeted therapeutic is advantageous or not in debugging the co-morbidity associated with diet-induced obesity (DIO) and the metabolic syndrome. We report herein on the positive effect of prohibitin (an adipose vascular marker)-targeted nanoparticle (PTNP) encapsulated in a proapoptotic peptide [(D)(KLAKLAK)(2), KLA] on DIO and dysfunctional adipose tissue, a major mediator of the metabolic syndrome, as evidenced by ectopic fat deposition. The systemic injection of DIO mice with a low dose of KLA-PTNP, rather than a bioconjugate composed of the same targeting peptide and KLA (Adipotide) resulted in a reduction in body weight, as evidenced by a significant decrease in serum leptin levels, in parallel with an antiobesity effect on dysfunctional adipose cells, including adipocytes and macrophages. In addition, the KLA-PTNP treatment resulted in a reduction in ectopic fat deposits in liver and muscle with the lipolytic action of elevated serum adiponectin, with no detectable hepatoxicity. Notably, drug delivery via PTNP that had accumulated in obese fat via the enhanced permeability and retention effect was enhanced by multivalent active targeting and cytoplasmic delivery into adipose endothelial cells via escaping from endosomes/lysosomes. Thus, vascular-targeted nanotherapy has the potential to contribute to the control of adipose function and ectopic fat deposition associated with obesity and the metabolic syndrome. (C) 2013 Elsevier B. V. All rights reserved.
- Elsevier science bvの論文
- 2013-10-28
著者
関連論文
- Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissues
- Comparison between a Multifunctional Envelope-Type Nano Device and Lipoplex for Delivery to the Liver
- Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue
- イオントフォレシスによる高分子の皮膚透過
- Assessment of MEF2A Mutations in Myocardial Infarction in Japanese Patients
- Validation of the Association Between the Gene Encoding 5-Lipoxygenase-Activating Protein and Myocardial Infarction in a Japanese Population
- Exclusion of the Catechol-O-Methyltransferase Gene from Genes Contributing to Salt-Sensitive Hypertension in Dahl Salt-Sensitive Rats
- Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis
- In Vivo Transdermal Delivery of Diclofenac by Ion-Exchange Iontophoresis with Geraniol(Biopharmacy)
- DNA Microarray Analysis of Whole Blood Cells and Insulin-Sensitive Tissues Reveals the Usefulness of Blood RNA Profiling as a Source of Markers for Predicting Type 2 Diabetes
- Assessment of Genetic Effects of Polymorphisms in the MCP-1 Gene on Serum MCP-1 Levels and Myocardial Infarction in Japanese
- Cold-Induced Changes in Gene Expression in Brown Adipose Tissue : Implications for the Activation of Thermogenesis
- miRNA発現解析から分かる褐色脂肪細胞と白色脂肪細胞の分化と起源の相違
- Quantitative Comparison of Adipocytokine Gene Expression during Adipocyte Maturation in Non-obese and Obese Rats
- Cell penetrating peptide-mediated systemic siRNA delivery to the liver
- A DNA Microarray-based Analysis of the Host Response to a Nonviral Gene Carrier: A Strategy for Improving the Immune Response
- イオントフォレシスによる高分子医藥の皮内送逹
- DDS技術による遺伝子・核酸医薬の将来 (特集 先端医療実用化のための最新DDS技術の動向)
- Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery
- Efficient Intradermal Delivery of Superoxide Dismutase Using a Combination of Liposomes and Iontophoresis for Protection against UV-Induced Skin Damage
- Quantitative Analysis of Serum Procollagen Type I C-Terminal Propeptide by Immunoassay on Microchip
- Ribonuclease protection assay on microchip electrophoresis
- A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
- Therapeutic Assessment of Cytochrome C for the Prevention of Obesity Through Endothelial Cell-targeted Nanoparticulate System